Pharmacy Regulatory Issues

A few of the key issues in the pharma industry are regulatory and legal Issues, long, uncertain research and development, process access, pricing, and patent Issues (Williams & Torrens, 2008). Pharmaceutical discoveries since the 1950s have helped to cut death rates for chronic as well as acute conditions, since the 1960, vaccines have greatly reduced the incidence of childhood diseases— many of which once killed or disabled thousands of American children (Williams & Torrens, 2008). The drug discovery and development process is time consuming, complex, and highly risky. At the same time, to ensure safety, the research-based pharmaceutical industry is one of the most heavily regulated in the country (Williams & Torrens, 2008). The industry needs
A drug goes through discovery and testing before it ever reaches a market, then there is monitoring and evaluating a drug’s safety that is more complex after it is approved and marketed (Williams & Torres, 2008). The major issue is that a drug is only innovative and life changing, if the patient actually has access to it. Access restrictions are particularly onerous for low-income patients, who lack the resources to pay for innovative medicines out of pocket (Williams & Torrens, 2008). The pharmaceutical industry has contributed to improvements in the nation’s health. Yet many complex issues remain unresolved including pricing, testing, approval procedures and standards, distribution and access issues, international equity, and legal and regulatory concerns (Williams & Torrens, 2008). The industry will likely change as technology advances and the needs and concerns of patients shift over time, we must be prepared to tackle the
People are living longer, and the need for more qualified healthcare professionals is growing. The lack of adequate medical facilities, professional isolation, limited support services, inadequate organizational settings, including lack of group practices, excessive workloads and time demands, limits on earnings, lack of social, cultural, and educational opportunities, and spouse’s influence (Gordon, Meister, & Hughes, 1992). Many incentives have been given in order to attempt to help improve the efforts of distribution of healthcare professionals. Technological innovation has also led to increased specialization of health care personnel, primarily during the last 40 years (Williams & Torrens, 2008). There are more restrictive elements have been blunted due to widespread physician and patient dissatisfaction, particularly with limits on choice. Medicine’s distaste of tightly controlled reimbursement and of non physicians’ attempts to control their work fueled much of this backlash (Lesser, Ginsburg, & Devers, 2003). Physician preferences now favor a more “controllable lifestyle, quality of life, and population growth are all a part of the need for more professionals in the field. (Williams & Torres,